Literature DB >> 9868969

Increased plasma lipoprotein(a) level in cardioembolic stroke with non-valvular atrial fibrillation.

H Okura, H Inoue, M Tomon, S Nishiyama, T Yoshikawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9868969     DOI： 10.2169/internalmedicine.37.995

Source DB:  PubMed          Journal:  Intern Med        ISSN： 0918-2918            Impact factor:   1.271


× No keyword cloud information.
  4 in total

Review 1.  Role of New Potential Biomarkers in the Risk of Thromboembolism in Atrial Fibrillation.

Authors:  Mario Piergiulio Pezzo; Antonella Tufano; Massimo Franchini
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241

2.  Association between lipoprotein(a) and thromboembolism in patients with non-valvular atrial fibrillation: a cross-sectional study.

Authors:  Jie Song; Xiaoxue Zhang; Meng Wei; Yakun Bo; Xianhui Zhou; Baopeng Tang
Journal:  Lipids Health Dis       Date:  2022-08-25       Impact factor: 4.315

Review 3.  A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation.

Authors:  Luxiang Shang; Ling Zhang; Yankai Guo; Huaxin Sun; Xiaoxue Zhang; Yakun Bo; Xianhui Zhou; Baopeng Tang
Journal:  Front Cardiovasc Med       Date:  2021-07-01

4.  Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study.

Authors:  Konstantinos N Aronis; Di Zhao; Ron C Hoogeveen; Alvaro Alonso; Christie M Ballantyne; Eliseo Guallar; Steven R Jones; Seth S Martin; Saman Nazarian; Brian T Steffen; Salim S Virani; Erin D Michos
Journal:  J Am Heart Assoc       Date:  2017-12-15       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.